$1.01
-0.065-6.02%
Last update: Nov 11, 10:28 AM
Exicure Inc (XCUR) Stock Price, Quote, News & History
XCURNASDAQ
Exicure agrees to sell its GPC-100 program assets to GPCRT for $4.8 million to maximize stockholder value.
You can purchase shares of Exicure (NASDAQ:XCUR) through any online brokerage.
Other companies in Exicure’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
There is no analysis for Exicure to provide a consensus price target.
The stock price for Exicure (NASDAQ: XCUR) is $1.015 last updated November 11, 2026 at 10:28 AM EST.
There are no upcoming dividends for Exicure.
Exicure does not have any upcoming earnings scheduled.
There is no upcoming split for Exicure.
Exicure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR...
